Martin Marietta Materials Inc. (0JZ0)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 499.68 |
|---|---|
| 52-week range | 466.31 – 716.70 |
| Return, 1 month / 3 months | +1.7% / −11.4% |
| Return, 1 year / 3 years | −19.8% / +22.5% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 28.5% |
| Worst drawdown (1 year) | -33.4% |
| Average daily value traded | 0.06M USD |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Martin Marietta Materials is an American supplier of heavy building materials based in Raleigh, North Carolina. The company produces aggregates such as crushed stone, sand and gravel, along with cement and ready-mixed concrete. Its customers are mainly in construction and infrastructure, including builders, contractors and public agencies that need basic materials for roads, buildings and other projects. The business centres on quarrying and processing stone and related products for use in civil works and commercial development.
Martin Marietta Materials Inc. trades under the code 0JZ0 on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Martin Marietta Materials Inc. (0JZ0) trades on the London Exchange in UK. It last closed at USD 499.68 on 19 October 2026.
Its price-based Market X-Ray is 33 out of 100 (a weak price profile), ranking 2,962 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 19.8% and over the last three months it fell 11.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 23 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -14.1% | ||
| From 52-week high | -29.3% | ||
| Momentum | 21 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.4% | ||
| 6-month return | -20.9% | ||
| 12-month return, skipping the last month | -21.2% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.4% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.06M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.1% |
|---|---|
| 1 month | +1.7% |
| 3 months | −11.4% |
| 6 months | −20.9% |
| 1 year | −19.8% |
| 3 years | +22.5% |
| 5 years | +39.2% |
Signals
| 50-day / 200-day average | 508.29 / 581.78 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 15.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | USD 0.8400 |
| 29 May 2026 | USD 0.8300 |
| 27 Feb 2026 | USD 0.8300 |
| 28 Nov 2025 | USD 0.8300 |
| 1 Sep 2025 | USD 0.8300 |
| 30 May 2025 | USD 0.7900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.